INAB Chart
See on advanced chart >
About
In8bio, Inc. was incorporated in Bermuda on February 8, 2016. On May 7, 2018, the company reincorporated in the United States in a domestication transaction in which it converted into a newly formed Delaware corporation, the company is a clinical-stage...
Read More
- HighlightA clinical-stage biopharmaceutical company that focused on gamma-delta T cell product candidates for solid and liquid tumors
- ExchangeNASDAQ
- Listing Date07/30/2021
- Established Date05/07/2018
- Full-time Employees31
- Address350 5th Avenue Suite 5330 New York New York 10118
- Tel1-646-6006438
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Pharmaceuticals